FDA veteran Pazdur warns that politics, ‘chaos’ are hurting agency
SAN FRANCISCO — Richard Pazdur, a veteran regulator at the Food and Drug Administration who left the agency…
AI firms believe mammograms can spot multiple health risks
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
Merck’s experimental pill lowered bad cholesterol as much as shots
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach…
Mass General Brigham turning to AI to ease primary care doctor shortage
Mass General Brigham has turned to artificial intelligence to address a critical shortage of primary care doctors, launching an…
Pharmalittle: no Trump tariffs on generics, Novo’s MASH deal
Oh, what a beautiful morning. Clear blue skies and delicious cool breezes are enveloping the Pharmalot campus, where…
UnitedHealth Group names Duke’s Michael Pencina chief AI scientist
Casey Ross covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and…
NYU plans to use AI to check CT scans for osteoporosis
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
What rescheduling marijuana means in law, politics and business
For years, removing marijuana from the highest tier of controlled substances has been a standard Democratic Party talking…
FDA plans advisory committee meeting on AI mental health devices
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
Abridge, Highmark Health testing use of AI for prior authorizations| STAT
Abridge is partnering with payer-provider Highmark Health to develop an artificial intelligence tool that would facilitate in-visit insurance…
Vinay Prasad returns to the FDA, weeks after his ouster
WASHINGTON — Vinay Prasad is returning to the Food and Drug Administration to resume his role overseeing vaccine,…
Vinay Prasad departs FDA | STAT
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…